NAD+ Research Compound
From: £59.99
Batch level verified
All Batches Purity Tested
HPLC & MS Verified
Fast Secure Postage
UK Based
Product Overview
NAD+ research compound supplied as a lyophilised vial for laboratory research. Manufactured to high purity standards and batch tested using HPLC and Mass Spectrometry (MS) verification. Endotoxin tested and produced under controlled laboratory conditions for research applications.
Full Product Specification
NAD+ Research Compound
Key Features
• Nicotinamide adenine dinucleotide (NAD+) studied as a central coenzyme involved in cellular energy metabolism
• Investigated in laboratory models examining mitochondrial function and metabolic pathways
• Commonly utilised in research involving cellular signalling, redox reactions, and biochemical processes
• Supplied as high purity lyophilised powder for research applications
Specifications
• Form: Lyophilised powder
• Purity: ≥99%
• Verification: HPLC and Mass Spectrometry; CoA available
• Manufacturing: Laboratory controlled conditions
Storage Conditions
• Unreconstituted: −20°C
• Reconstituted (bacteriostatic water): 2–8°C
• Protect from light; avoid freeze thaw cycles
Research Use Only Disclaimer
• Laboratory research only
• Not for human or clinical use
• Handled only by qualified personnel
Additional Information
• CAS Number: 53-84-9
• Molecular Formula: C21H27N7O14P2
All Batches Purity Tested
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
For Research Use Only
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
Not for Human Consumption
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store Safely at All Times
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.
